Catalyst Wire Dossier Catalyst Wire Dossier

Walter Reed (WR) 279,396

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Walter Reed (WR) 279,396, covering 2017-08-23 to 2017-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama [Phase 3]

See pricing